Clinical Trial

Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study employs a double-blind, randomized clinical trial design with 60 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: the experimental group receives combined hyaluronic acid and Triamcinolone Acetonide injections, while the control group receives hyaluronic acid alone injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-13.
Trial Details
NCT Number NCT06935877
Lead Sponsor Shin Kong Wu Ho-Su Memorial Hospital
Conditions Subdeltoid Bursitis of the Shoulder
Enrollment 60 participants
Start Date 2025-04-25
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-24